Effects of ethinylestradiol and testosterone implants on hepatic microsomal cytochrome P450 monooxygenases of birth gonadectomized male and female Dark Agouti rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 39, Issue 5 PART 1, 1991, Pages 741-749

  Reilly, Paul E B ^a   Mason, Steven R ^a   Hooper, Wayne D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 OXYGENASE; ETHINYLESTRADIOL; N DEMETHYLASE; TESTOSTERONE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ARTICLE; GONADECTOMY; LIVER MICROSOME; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CYTOCHROME P-450 ENZYME SYSTEM; DRUG IMPLANTS; ENZYME INDUCTION; ETHINYL ESTRADIOL; FEMALE; ISOENZYMES; KINETICS; MALE; MICROSOMES, LIVER; ORCHIECTOMY; OVARIECTOMY; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; TESTOSTERONE;

AGOUTI; ANIMALIA;

EID: 0025952834     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(91)90375-F     Document Type: Article

References (76)

1. Pregnenolone-16α-carbonitrile: a new type of inducer of drug-metabolizing enzymes
2. Separation, purification, and characterization of a novel form of hepatic cytochrome P450 from rats treated with pregnenolone 16α-carbonitrile
3. Immunochemical evidence for induction of a common form of hepatic cytochrome P450 in rats treated with pregnenolone 16α-carbonitrile and other steroidal and nonsteroidal agents
4. Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16α-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver in vivo
5. Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism
6. Induction of the hepatic mixed function oxidase system by synthetic glucocorticoids: transcriptional and post-transcriptional regulation
7. Regulation of phenobarbital-inducible cytochrome P-450s in rat and mouse liver following dexamethasone administration and hypophysectomy
8. Purification and characterization of four catalytically active testosterone 6β-hydroxylase P-450s from rat liver microsomes: comparison of a novel form with three structurally and functionally related forms
9. Regulation of rat hepatic cytochrome P450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes
10. Hormonal regulation of rat liver microsomal enzymes
11. Evidence for functional and structural multiplicity of pregnenolone-16α-ccabonitrile-inducible cytochrome P-450 isozymes in rat liver microsomes
12. Immunochemical evidence for multiple steroid-inducible hepatic cytochromes P-450 in the rat
13. Participation of a rat liver cytochrome P-450 induced by pregnenolone 16α-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin
14. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450
15. 3c from rabbit liver microsomes
16. Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat
17. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450 IIIA gene subfamily
18. Identification of an inducible form of cytochrome P-450 in human liver
19. Characterization of the rat and human microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism
20. Identification of a polymorphically expressed member of the human cytochrome P-450 III family
21. Studies on the expression and metabolic capabilities of human liver cytochrome P450 IIIA5 (HLp3)
22. Isolation and characterization of human fetal liver cytochrome P450HLp2: A third member of the P450III gene family
23. Fetus-specific expression of a form of cytochrome P-450 in human livers
24. Identification of the rabbit and human cytochromes P450 IIIA as the major enzymes involved in the N-demethylation of diltiazem
25. 3 hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam
26. 3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver
27. Oxidation of midazolam and triazolam by human liver cytochrome P450 IIIA4
28. Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme
29. Purification and characterization of four catalytically active testosterone 6β hydroxylase P-450s from rat liver microsomes: comparison of a novel form with three structurally and functionally related forms
30. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450
31. The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450 IIIA induction
32. Oxidation of 17α-ethynylestradiol by human liver cytochrome P-450
33. 17β-Estradiol 2- and 4-hydroxylation catalyzed by rat hepatic cytochrome P-450: roles of individual forms, inductive effects, developmental patterns, and alterations by gonadectomy and hormone replacement
34. Cytochrome P-450-catalyzed dehydrogenation of 1,4-dihydropyridines
35. Oxidation of quinidine by human liver cytochrome P-450
36. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs
37. Relation of the pituitary gland to the actions of testosterone on hepatic ethylmorphine metabolism in rats
38. On the obligatory role of the hypophysis in sexual differentiation of hepatic metabolism in rats
39. Hypothalamo-pituitary regulation of cytochrome P-450 15β apoprotein levels in rat liver
40. Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16α-hydroxylase cytochrome P-450 apoprotein in the rat
41. Pituitary regulation of the male-specific steroid 6β-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppressive influence of growth hormone and thyroxine acting at a pretranslational level
42. 6β (testosterone 6β-hydroxylase) mRNAs in rat liver
43. Divergent effects of cycloheximide on the induction of class II and class III cytochrome P450 mRNAs in cultures of adult rat hepatocytes
44. Pregnenolone 16α-inducible P-450 gene family: gene conversion and differential regulation
45. Sexual differences of the hypophyses and their determination by the gonads
46. Hormone administration: peripheral and intracranial implants
47. Continued development of hepatic gamma-glutamyltranspeptidase-positive foci upon withdrawal of 17α-ethinylestradiol in diethylnitrosamine-initiated rats
48. Microsomal enzymes involved in toxicology analysis and separation
49. The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism
50. Protein measurement with the Folin phenol reagent
51. Adverse drug interactions with cimetidine: competitive inhibition of monooxygenase-dependent N-demethylation of morphine
52. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction
53. 18 cartridges
54. Sex differences and endocrine regulation of morphine oxidation in rat liver
55. On the substrate specificity of cytochrome P450 IIIA1
56. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism
57. Characterization of rat and human liver microsomal cytochrome P450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism
58. Human cytochrome P450 IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450 IIE1
59. Regulation of cytochrome P-450-dependent catechol estrogen formation in rat liver microsomes. Evidence for involvement of estrogen receptors
60. Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17α-ethinyloestradiol. Relative activities of rat and human liver enzymes
61. Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s
62. Sex differences in the effects of microsomal enzyme inducers on hepatic phase 1 drug metabolism in the rat
63. Sexually dimorphic response of rat hepatic monooxygenases to low-dose phenobarbital
64. Effects of synthetic estrogens and estrogen-progestin combinations on the hepatic microsomal enzyme system
65. Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver
66. Dose-response relationships in promotion of rat hepatocarcinogenesis by 17α-ethinylestradiol
67. Intrahepatic cholestasis induced by drugs and chemicals
68. Hepatic catabolism of rat and human lipoproteins in rats treated with 17α-ethinylestradiol
69. Increased binding of low density lipoproteins to liver membranes from rats treated with 17α-ethinylestradiol
70. Decreased liver cytochrome P450 in rats caused by norethindrone or ethynyloestradiol
71. Self-catalyzed destruction of cytochrome P450: covalent binding of ethynyl sterols to prosthetic heme
72. Suicidal Destruction of Cytochrome P-450 During Oxidative Drug Metabolism
73. Suicide substrates for drug metabolizing enzymes: mechanisms and biological consequences
74. Specific inactivation of hepatic fatty acid hydroxylases by acetylenic fatty acids
75. b: a mechanistic reappraisal
76. Enzymology of rat liver cytochromes P-450